Predictors of health care costs in adults with diabetes

Diabetes Care

Volumn 28, Issue 1, 2005, Pages 59-64

  Gilmer, Todd P ^a   O'Connor, Patrick J ^b   Rush, William A ^b   Crain, A Lauren ^b   Whitebird, Robin R ^b   Hanson, Ann M ^b   Solberg, Leif I ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICARE; MULTIVARIATE ANALYSIS; SOCIOECONOMICS;

CORONARY DISEASE; COSTS AND COST ANALYSIS; DATABASES, FACTUAL; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; EDUCATIONAL STATUS; FEMALE; HEART DISEASES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; INCOME; MALE; MEDICAL RECORDS; MIDDLE AGED; MINNESOTA; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES;

EID: 11844298970     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.1.59     Document Type: Article

References (46)

1. Selby J, Grumbach K, Quesenberry CJ, Schmittdiel J, Truman A: Differences in resource use and costs of primary care in a large HMO according to physician specialty. Health Serv Res 34:503-518, 1999
2. Selby JV, Ray GT, Zhang D, Colby CJ: Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 20:1396-1402, 1997
3. Brown JB, Nichols GA, Glauber HS, Bakst AW: Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care 22:1116-1124, 1999
4. Browne GB, Arpin K, Corey P, Fitch M, Gafni A: Individual correlates of health service utilization and the cost of poor adjustment to chronic illness. Med Care 28:43-58, 1990
5. Sidorov J, Shull R, Tomcavage J, Girolami S, Lawton N, Harris R: Does diabetes disease management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria. Diabetes Care 25:684-689, 2002
6. Fishman P, Korff MV, Hecht J: Chronic care costs in managed care. Health Aff (Millwood) 16:239-247, 1997
7. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
8. Gilmer TP, O'Connor PJ, Manning WG, Rush WA: The cost to health plans of poor glycemic control. Diabetes Care 20:1847-1853, 1997
9. O'Connor P, Crabtree B, Nakamura R, Kelley D: Hospitalization experience of Navajo subjects with type II diabetes and matched controls: an historical cohort study. J Clin Epidemiol 43:881-890, 1990
10. Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291:335-342, 2004
11. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
12. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
13. Nyman MA, Murphy ME, Schryver PG, Naessens JM, Smith SA: Improving performance in diabetes care: a multicomponent intervention. Eff Clin Pract 3:205-212, 2000
14. Sperl-Hillen J, O'Connor PJ, Carlson RR, Lawson TB, Halstenson C, Crowson T, Wuorenma J: Improving diabetes care in a large health care system: an enhanced primary care approach. Jt Comm J Qual Improv 26:615-622, 2000
15. Sutherland JE, Hoehns JD, O'Donnell B, Wiblin RT: Diabetes management quality improvement in a family practice residency program. J Am Board Fam Pract 14:243-251, 2001
16. Sidorov J, Gabbay R, Harris R, Shull RD, Girolami S, Tomcavage J, Starkey R, Hughes R: Disease management for diabetes mellitus: impact on Hemoglobin Alc. Am J Manag Care 6:1217-1226, 2000
17. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20:614-620, 1997
18. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7-22, 2002
19. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB: Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA 285:1585-1591, 2001
20. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy. Lancet 355:253-259, 2000
21. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351:1755-1762, 1998
22. Schrier R, Estacio R, Jeffers B: Appropriate blood pressure control in NIDDM (ABCD Trial). Diabetologia 39:646-654, 1996
23. Shorr RI, Franse LV, Resnick HE, Di Bari M, Johnson KC, Pahor M: Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Geriatr Soc 48:264-267, 2000
24. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934-942, 2000
25. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069-1078, 2001
26. Bruce DG, Casey GP, Grange V, Clarnette RC, Almeida OP, Foster JK, Ives FJ, Davis TM: Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study. Diabetes Res Clin Pract 61:59-67, 2003
27. Musselman DL, Betan E, Larsen H, Phillips LS: Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 54:317-329, 2003
28. O'Connor P, Rush W, Pronk N, Cherney L: Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value and cost of survey and database methods. Am J Manag Care 4:335-342, 1998
29. Stein AD, Lederman RI, Shea S: The Behavioral Risk Factor Surveillance System questionnaire: its reliability in a statewide sample. Am J Public Health 83:1768-1772, 1993
30. Little RJA and Rubin DB: Statistical Analysis with Missing Data. New York, Wiley, 1987
31. Report to the President: prescription drug coverage, spending, utilization, and prices [article online], 2000. Department of Health and Human Services. Available from http://www.aspe.hhs.gov/health/reports/drugstudy/index. htm. Accessed 12 November 2004
32. Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC: Effect of improved glycemic control on health care costs and utilization. JAMA 285:182-189, 2001
33. Brandle M, Zhou H, Smith B, Marriott D, Burke R, Tabaei B, Brown M, Herman W: The direct medical cost of type 2 diabetes. Diabetes Care 26:2300-2304, 2003
34. O'Connor PJ, Solberg LI, Whitebird RR, Grain AL, Christianson JC, Rush WA, Amundson G, Asche SE: The impact of clinic and medical group characteristics on diabetes care outcomes in primary care clinics (Abstract). Diabetes 53 (Suppl. 2): A288, 2004
35. Feld S: Introduction. Endocr Pract 8 (Suppl. 1):40-82, 2002
36. Institute for Clinical Systems Improvement: Diabetes Mellitus (Type 2) Care Guideline for Patients and Families. Bloomington, MN, ICSI, 2003
37. American Diabetes Association: Clinical practice recommendations 2003. Diabetes Care 26 (Suppl. 1):S1-S156, 2003
38. The CDC Diabetes Cost-effectiveness Group: Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 287:2542-2551, 2002
39. UK Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 317:713-720, 1998
40. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
41. Haffner SM: The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease. Diabetes Care 20:469-471, 1997
42. Hansson L, Lindholm LH, Ekbom T, Dahlof B, Lanke J, Schersten B, Wester PO, Hedner T, de Faire U: Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 354:1751-1756, 1999
43. UK Prospective Diabetes Study Group: Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 317:720-726, 1998
44. Herman WH, Alexander CM, Cook JR, Boccuzzi SJ, Musliner TA, Pedersen TR, Kjekshus J, Pyorala K: Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes: findings from the Scandinavian Simvastatin Survival Study. Diabetes Care 22:1771-1778, 1999
45. O'Connor PJ, Sperl-Hillen JM, Pronk NP, Murray T: Primary care clinic-based chronic disease care. Dis Manag Health Outcomes 9:691-698, 2001
46. Johnson PE, Veazie PJ, Kochevar L, O'Connor PJ, Potthoff SJ, Verma D, Dutta P: Understanding variation in chronic disease outcomes. Health Care Manag Sci 5:175-189, 2002